X. Tian, Q. Yang, and J. Wu, “Effect of Apatinib Mesylate on Clinical Remission Rate and Adverse Reactions in Patients with Advanced Primary Hepatocellular Carcinoma”, IJBLS, vol. 5, no. 1, pp. 13–16, Feb. 2024, doi: 10.54097/t3s4wp88.